Cargando…
RANKL/RANK: from bone loss to the prevention of breast cancer
RANK and RANKL, a receptor ligand pair belonging to the tumour necrosis factor family, are the critical regulators of osteoclast development and bone metabolism. Besides their essential function in bone, RANK and RANKL have also been identified as the key factors for the formation of a lactating mam...
Autores principales: | Sigl, Verena, Jones, Laundette P., Penninger, Josef M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133443/ https://www.ncbi.nlm.nih.gov/pubmed/27881737 http://dx.doi.org/10.1098/rsob.160230 |
Ejemplares similares
-
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020) -
RANKL/RANK control Brca1 mutation-driven mammary tumors
por: Sigl, Verena, et al.
Publicado: (2016) -
The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020) -
RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016) -
The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)